Pulsed Radiofrequency in Trigeminal Neuralgia

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT04355221
Collaborator
(none)
60
3
36

Study Details

Study Description

Brief Summary

The current study investigated the efficacy of pulsed radiofrequency in pain reduction in TN patients and compared the efficacy and the impact on the quality of life of the standard technique with a prolonged duration technique and a higher voltage one.

Entire enrolled patients were diagnosed as classic TN according to the international headache society classification (IHS, 2013) and underwent brain MRI and MRA to exclude secondary causes. Patients were randomly divided into three groups, Group A patients underwent PRF using the standard settings, group B patients underwent PRF with prolonged duration and Group C patients underwent PRF with higher voltage. VAS and pain amplitude reduction were recorded before the intervention and 1 hour, 1 day, 1week, 1 month, 6 months and 1year after it. Quality of life was assessed before and 1 year after the intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: pulsed radiofrequency
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Pulsed Radiofrequency in Treatment of Classic Trigeminal Neuralgia (Prolonged Duration Versus Higher Voltage)
Actual Study Start Date :
Jul 1, 2016
Actual Primary Completion Date :
Jul 1, 2019
Actual Study Completion Date :
Jul 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group A

using the standard settings of pulsed radiofrequency technique (PRFT). two cycles, each one for 2 minutes at 45 Volts (V) with a pulse width of 10 milliseconds (ms) and a pulse frequency of 4 Hertz (Hz). The cut-off needle tip temperature is set at 420 Celsius (C).

Procedure: pulsed radiofrequency
Pulsed radiofrequency of the trigeminal nerve using NeuroTherm NT 1100 RF generator device

Experimental: Group B

using prolonged duration of PRFT. four cycles, each one for 2 minutes at 45V with a pulse width of 10ms and a pulse frequency of 4Hz. The cut-off needle tip temperature is set at 420C.

Procedure: pulsed radiofrequency
Pulsed radiofrequency of the trigeminal nerve using NeuroTherm NT 1100 RF generator device

Experimental: Group C

using higher voltage PRFT.. two cycles, each one for 2 minutes at 60V with a pulse width of 10ms and a pulse frequency of 4Hz. The cut-off needle tip temperature is set at 420C.

Procedure: pulsed radiofrequency
Pulsed radiofrequency of the trigeminal nerve using NeuroTherm NT 1100 RF generator device

Outcome Measures

Primary Outcome Measures

  1. Pain amplitude reduction [1 year]

    compare the pain amplitude reduction in the three groups using the visual analogue pain scale

Secondary Outcome Measures

  1. RAND 36-Item Health Survey [1 year]

    compare the quality of life changes before and after intervention using RAND 36-Item Health Survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients are diagnosed as classic TN according to the international headache society classification of headache disorders

  • Visual analogue scale (VAS) for pain of at least 4 or more.

  • Pain is refractory to medical treatment (for at least 3 months with three drugs including carbamazepine with optimum dosage) or patients who developed intolerable side effects from medications.

Exclusion Criteria:
  • Symptomatic (secondary) TN: which is causes by structural lesion other than neurovascular compression such as multiple sclerosis, tumors, stroke or trauma according to the international headache society classification (IHS, 2013).

Local infection at the site of the needle puncture. Bleeding tendency or coagulopathy. Previous treatment with invasive treatments such as radiofrequency thermo coagulation, destructive chemical injection, gamma knife treatment, percutaneous balloon micro-compression or microvascular decompression.

Major mental or psychiatric disorders. History of drug abuse.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mansoura University
ClinicalTrials.gov Identifier:
NCT04355221
Other Study ID Numbers:
  • MD/16.06.26
First Posted:
Apr 21, 2020
Last Update Posted:
Apr 21, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mansoura University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2020